AdvisorShares launches PSIL, a Psychedelics ETF

By: ETFdb
AdvisorShares, a leading sponsor of actively managed exchange traded funds (ETFs), today announced the launch of the AdvisorShares Psychedelics ETF . PSIL invests in the emerging psychedelic drugs sector, offering exposure to biotechnology, pharmaceutical, and life sciences companies leading the way in this nascent industry.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.